Regulator of differentiation 1 (ROD1) binds to the amphipathic C-terminal peptide of thrombospondin-4 and is involved in its mitogenic activity

Journal of Cellular Physiology

Volumn 220, Issue 3, 2009, Pages 672-679

  Sadvakassova, Gulzhakhan ^a   Dobocan, Monica C ^a   Difalco, Marcos R ^b   Congote, Luis F ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD34 ANTIGEN; ERYTHROPOIETIN; MATRIX PROTEIN; POLYPYRIMIDINE TRACT BINDING PROTEIN; PROTEIN; REGULATOR OF DIFFERENTIATION 1 PROTEIN; RNA POLYMERASE II; THROMBOSPONDIN 4; UNCLASSIFIED DRUG; GLYCOPHORIN; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; RNA BINDING PROTEIN; ROD1 PROTEIN, HUMAN; THROMBOSPONDIN; ZIDOVUDINE;

ANEMIA; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; ERYTHROCYTE; EXON; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KIDNEY EPITHELIUM; MALE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA SPLICING; SKIN FIBROBLAST; ACTIVE TRANSPORT; ANIMAL; BINDING SITE; BLOOD; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; EPITHELIUM CELL; ERYTHROID PRECURSOR CELL; ERYTHROLEUKEMIA; ERYTHROPOIESIS; FIBROBLAST; GENETIC TRANSDUCTION; GENETICS; KIDNEY; METABOLISM; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE; SKIN; TIME;

MUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANEMIA; ANIMALS; BINDING SITES; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; FIBROBLASTS; GLYCOPHORIN; HUMANS; KIDNEY; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; POLYPYRIMIDINE TRACT-BINDING PROTEIN; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA-BINDING PROTEINS; SKIN; THROMBOSPONDINS; TIME FACTORS; TRANSDUCTION, GENETIC; ZIDOVUDINE;

EID: 67650366915     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21817     Document Type: Article

References (43)

1. Adams JC, Lawler J. 2004. The thrombospondins. Int J Biochem Cell Biol 36:168-961.
2. Ashiya M, Grabowski PJ. 1997. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: Evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. RNA 3:996-1015.
3. Boutz PL, Chawla G, Stoilov P, Black DL. 2007a. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev 21:71-84.
4. Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, Ostrow K, Shiue L, Ares M, Jr., Black DL. 2007b. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev 21:1636-1652.
5. Brown EJ, Frazier WA. 2001. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 11:130-135.
6. Chan RC, Black DL. 1997. The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream. Mol Cell Biol 17:4667-4676.
7. Chapman RD, Conrad M, Eick D. 2005. Role of the mammalian RNA polymerase II C-terminal domain (CTD) nonconsensus repeats in CTD stability and cell proliferation. Mol Cell Biol 25:7665-7674.
8. Chung J, Gao AG, Frazier WA. 1997. Thrombospondin acts via integrin-associated protein to activate the platelet integrin alphaIIbbeta3. J Biol Chem 272:14740-14746.
9. Congote LF. 2006. The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1. Biochem Biophys Res Commun 343:617-622.
10. Congote LF. 2007. Serpin A1 and CD91 as host instruments against HIV-1 infection: Are extracellular antiviral peptides acting as intracellular messengers? Virus Res 125:119-134.
11. Congote LF, Temmel N. 2004. The C-terminal 26-residue peptide of serpin A1 stimulates proliferation of breast and liver cancer cells: Role of protein kinase C and CD47. FEBS Lett 576:343-347.
12. Congote LF, Difalco MR, Gibbs BF. 2004. The C-terminal peptide of thrombospondin-4 stimulates erythroid cell proliferation. Biochem Biophys Res Commun 324:673-678.
13. Congote LF, DiFalco MR, Gibbs BF. 2005. Thrombospondin 1, produced by endothelial cells under the action of erythropoietin, stimulates thymidine incorporation into erythroid cells and counteracts the inhibitory action of insulin-like growth factor binding protein 3. Cytokine 30:248-253.
14. Congote LF, Temmel N, Sadvakassova G, Dobocan MC. 2008. Comparison of the effects of serpin A1, a recombinant serpin A1-IGF chimera and serpin A1 C-terminal peptide on wound healing. Peptides 29:39-46.
15. DiFalco MR, Congote LF. 1997. Preparation of a recombinant chimera of insulin-like growth factor II and interleukin 3 with high proliferative potency for hematopoietic cells. Biochem J 326:407-413.
16. DiFalco MR, Congote LF. 2002. Antagonism between interleukin 3 and erythropoietin in mice with azidothymidine-induced anemia and in bone marrow endothelial cells. Cytokine 18:51-60.
17. DiFalco RE, Dufresne L, Congote LF. 1998. Efficacy of an insulin-like growth factor-interleukin-3 fusion protein in reversing the hematopoietic toxicity associated with azidothymidine in mice. J Pharmacol Exp Therapeutics 284:449-454.
18. Dobocan MC, Sadvakassova G, Congote LF. 2009. Chaperonin 10 as an endothelial-derived differentiation factor: Role of glycogen synthase kinase-3. J Cell Physiol 219:470-476.
19. Hines M, Nielsen L, Cooper-White J. 2008. The hematopoietic stem cell niche: What are we trying to replicate? J Chem Technol Biotechnol 83:421-443.
20. Hoang T. 2004. The origin of hematopoietic cell type diversity. Oncogene 23:7188-7198.
21. Huang HM, Chang TW, Liu JC. 2004. Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1/2 and deactivating p38 MAP kinase. Biochem Biophys Res Commun 320:1247-1252.
22. Huttelmaier S, Illenberger S, Grosheva I, Rudinger M, Singer RH, Jockusch BM. 2001. Raver1, a dual compartment protein, is a ligand for PTB/hnRNPI and microfilament attachment proteins. J Cell Biol 155:775-785.
23. Larsen MR, Sorensen GL, Fey SJ, Larsen PM, Roepstorff P. 2001. Phospho-proteomics: Evaluation of the use of enzymatic de-phosphorylation and differential mass spectrometric peptidemass mapping for site specific phosphorylation assignment in proteins separated by gel electrophoresis. Proteomics 1:223-238.
24. Li Q, Congote LF. 1995. Bovine fetal-liver stromal cells support erythroid colony formation: Enhancement by insulin-like growth factor II. Exp Hematol 23:66-73.
25. Makeyev EV, Zhang J, Carrasco MA, Maniatis T. 2007. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 27:435-448.
26. McGlincy NJ, Smith CW. 2008. Alternative splicing resulting in nonsense-mediated mRNA decay: What is the meaning of nonsense? Trends Biochem Sci 33:385-393.
27. Meininghaus M, Chapman RD, Horndasch M, Eick D. 2000. Conditional expression of RNA polymerase II in mammalian cells. Deletion of the carboxyl-terminal domain of the large subunit affects early steps in transcription. J Biol Chem 275:24375-24382.
28. Norton JT, Wang C, Gjidoda A, Henry RW, Huang S. 2009. The perinucleolar compartment is directly associated with DNA. J Biol Chem 284:4090-4101.
29. Perez I, Lin CH, McAfee JG, Patton JG. 1997. Mutation of PTB binding sites causes misregulation of alternative 3′ splice site selection in vivo. RNA 3:764-778.
30. Phatnani HP, Greenleaf AL. 2006. Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev 20:2922-2936.
31. Reiher FK, Volpert OV, Jimenez B, Crawford SE, Dinney CP, Henkin J, Haviv F, Bouck NP, Campbell SC. 2002. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics. Int J Cancer 98:682-689.
32. Rhee M, Davis P. 2006. Mechanism of uptake of C105y, a novel cell-penetrating peptide. J Biol Chem 281:1233-1240.
33. Sandoval C, Stojanova A, DiFalco MR, Congote LF. 2003. The fusion of IGF I with stromal cell-derived factor I or alpha1-proteinase inhibitor alters their mitogenic or chemotactic activities while keeping their ability to inhibit HIV-1-gp120 binding. Biochem Pharmacol 65:2055-2063.
34. Sawicka K, Bushell M, Spriggs KA, Willis AE. 2008. Polypyrimidine-tract- binding protein: A multifunctional RNA-binding protein. Biochem Soc Trans 36:641-647.
35. Scadden DT. 2006. The Stem-Cell Niche as an Entity of Action. Nature 441:1075-1079.
36. Schofield R. 1978. Relationship between spleen colony-forming cell and hematopoietic stem-cell-hypothesis. Blood Cells 4:7-25.
37. Spellman R, Llorian M, Smith CW. 2007. Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol Cell 27:420-434.
38. Teitell MA, Mikkola HKA. 2006. Transcriptional activators, repressors, and epigenetic modifiers controlling hematopoietic stem cell development. Pediatric Res 59:33R-39R.
39. Tossi A, Sandri L, Giangaspero A. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
40. Wollerton MC, Gooding C, Robinson F, Brown EC, Jackson RJ, Smith CW. 2001. Differential alternative splicing activity of isoforms of polypyrimidine tract binding protein (PTB). RNA 7:819-832.
41. Yamamoto H, Tsukahara K, Kanaoka Y, Jinno S, Okayama H. 1999. Isolation of a mammalian homologue of a fission yeast differentiation regulator. Mol Cell Biol 19:3829-3841.
42. Yuryev A, Patturajan M, Litingtung Y, Joshi RV, Gentile C, Gebara M, Corden JL. 1996. The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins. Proc Natl Acad Sci USA 93:6975-6980.
43. Zhang JW, Li LH. 2008. Stem cell niche: Microenvironment and beyond. J Biol Chem 283:9499-9503.